Draupnir Bio

biotech · Copenhagen, DK

Biotech developing oral small molecule degraders for extracellular proteins.

In the network

Shares the most investors with (number = shared investors):

Create a free EquityFlow account to see Draupnir Bio's 1 funding round, 4 investors, 12 similar companies.